Scholarlink

Background <p>Dystrophinopathy is severe X-linked recessive muscle disease caused by mutations in <i>DMD</i> gene. There is an increasing number of deep intronic variants in <i>DMD</i> gene, and understanding the pathogenic mechanisms of intronic variants can help the diagnosis and treatment of patients with DMD.</p> Objective <p>To identify two novel splice site variants in two families affected with Dystrophinopathy.</p> Methods <p>Two children with Duchenne muscular dystrophy (DMD) caused by <i>DMD</i> gene variants diagnosed at Women and Children’s Hospital of Ningbo University in April 2024 and August 2024 were selected as the subject. Genomic DNA was extracted from peripheral blood samples of the children and subjected to whole exome sequencing. Suspected splicing variant was verified by Sanger sequencing of family members. The splicing effects of the variant on <i>DMD</i> was assessed in a minigene assay, and X chromosome inactivation (XCL) analysis was performed for female carriers in 2 families.</p> Results <p>Two rare intronic variants were identified in DMD patients. One variant, NM_004006.3: c.9807 + 2dup of <i>DMD</i> identified in patient 1, leading to the retention of 21 intronic nucleotides, introducing a truncated protein (p.Ala3270_Met3685delinsValLysLeuPheThrPhe). The other variant, NM_004006.3: c.5739 + 326T &gt; G of <i>DMD</i> identified in patient 2, resulted in the retention of 43 or 19 intronic nucleotides, introducing a truncated protein(p.Glu1914Metfs*3). X-chromosome inactivation (XCI) patterns identified the mother of patient 2 were moderately skewed with 83.1% (normal allele)/16.9% (mutant allele) when compared with the sister of patient 2 with 45.1%/54.9%.</p> Conclusion <p>Our study discovered two novel splicing mutation of <i>DMD</i> in two DMD patients, which expand the variant spectrum of <i>DMD</i> and provide precise genetic diagnosis of DMD for timely therapy. XCI may explained the asymptomatic of female carriers of DMD.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Decoding splicing complexity: integrated genomic analysis reveals two novel pathogenic variants in Chinese dystrophinopathy pedigrees

  • 期刊论文

  • 发表日期：

    2025年9月1日

查看全文
  • Yingwen Liu,
  • Lulu Yan,
  • Yuxin Zhang,
  • Chunxiao Han,
  • Changshui Chen,
  • Haibo Li,
  • Yahua Zhang

摘要

Background

Dystrophinopathy is severe X-linked recessive muscle disease caused by mutations in DMD gene. There is an increasing number of deep intronic variants in DMD gene, and understanding the pathogenic mechanisms of intronic variants can help the diagnosis and treatment of patients with DMD.

Objective

To identify two novel splice site variants in two families affected with Dystrophinopathy.

Methods

Two children with Duchenne muscular dystrophy (DMD) caused by DMD gene variants diagnosed at Women and Children’s Hospital of Ningbo University in April 2024 and August 2024 were selected as the subject. Genomic DNA was extracted from peripheral blood samples of the children and subjected to whole exome sequencing. Suspected splicing variant was verified by Sanger sequencing of family members. The splicing effects of the variant on DMD was assessed in a minigene assay, and X chromosome inactivation (XCL) analysis was performed for female carriers in 2 families.

Results

Two rare intronic variants were identified in DMD patients. One variant, NM_004006.3: c.9807 + 2dup of DMD identified in patient 1, leading to the retention of 21 intronic nucleotides, introducing a truncated protein (p.Ala3270_Met3685delinsValLysLeuPheThrPhe). The other variant, NM_004006.3: c.5739 + 326T > G of DMD identified in patient 2, resulted in the retention of 43 or 19 intronic nucleotides, introducing a truncated protein(p.Glu1914Metfs*3). X-chromosome inactivation (XCI) patterns identified the mother of patient 2 were moderately skewed with 83.1% (normal allele)/16.9% (mutant allele) when compared with the sister of patient 2 with 45.1%/54.9%.

Conclusion

Our study discovered two novel splicing mutation of DMD in two DMD patients, which expand the variant spectrum of DMD and provide precise genetic diagnosis of DMD for timely therapy. XCI may explained the asymptomatic of female carriers of DMD.